Search results

Order by most recent / most popular / relevance

Results: 1-10 of 17

Limits on discovery in IPRs: no fishing expeditions for information relating to infringement

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
-
USA
-
April 15 2013

Recent inter partes review (IPR) orders confirm that the scope of discovery in IPR is significantly narrower than the broad-ranging discovery

IPR and PGR - they are not "American oppositions"

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
-
USA
-
March 18 2013

The America Invents Act (AIA) creates two new methods for third parties to challenge issued patents in the USPTO: inter partes review (IPR) and

America Invents Act podcast: Erika Arner and Joe Palys on post-grant review

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
-
USA
-
January 7 2013

Several new provisions of the America Invents Act (AIA) significantly impact the U.S. patent system. One of these provisions, post-grant review

Supreme Court decides to hear two new patent cases

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
-
USA
-
October 9 2012

As the U.S. Supreme Court begins its 2012 October term, the Court added two new patent-related cases to its docket. In Bowman v. Monsanto Corp., No. 11-796, the Court will consider the extent of patent rights in the sale of genetically altered seeds

Golan v. Holder

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
-
USA
-
April 19 2012

Golan v. Holder is a Supreme Court case whose decision will potentially affect the copyright status of a large body of works of art, including well-known music and films

A summary of the Supreme Court’s Prometheus decision

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
-
USA
-
March 21 2012

On March 20, 2012, the Supreme Court issued its much-anticipated decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc., unanimously holding that Prometheus’s claims, directed to methods for optimizing the efficacy of a drug, are directed laws to of nature and, consequently, not patent-eligible under 35 U.S.C. 101

Supreme Court argument preview: Golan v. Holder - oral argument scheduled Oct. 5, 2011

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
-
USA
-
October 3 2011

Eight years ago in Eldred v. Ashcroft, the Supreme Court addressed Congress’s power under the Progress Clause of the Constitution, which provides Congress with the ability to grant copyrights and patents to “promote the Progress of Science and the useful Arts"

Business methods in 2011: business as usual?

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
-
USA
-
August 19 2011

One year ago, the United States Supreme Court ruled that business methods cannot be categorically excluded from patenting in its landmark Bilski v. Kappos decision

Podcast: Erika Arner discusses Bilski, one year later

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
-
USA
-
August 9 2011

A year ago, the U.S. Supreme Court handed down its long-awaited Bilski v. Kappos ruling

A summary of the Supreme Court’s Stanford v. Roche Molecular Systems, Inc. decision

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
-
USA
-
June 8 2011

This week, the Supreme Court issued its decision in Stanford v. Roche Molecular Systems, Inc., holding that the Bayh-Dole Act, which allows federal contractors to “elect to retain title” to patents developed with federal money, does not automatically vest contractors with patent rights to federally funded inventions or otherwise authorize contractors to unilaterally take title to such inventions

next >